Anti-Cancer Medicines get cheaper from November 9, with 1,031 formulations seeing price cuts and annual consumer savings estimated at ₹3,502 crore.
Read MoreDepartment of Pharmaceuticals
PRIP Scheme: Second Call for Applications Under ₹5,000 Crore Scheme Opens
PRIP Scheme opens its second call under the ₹5,000 crore initiative, inviting pharma and MedTech projects from startups, MSMEs and industry.
Read MorePharmaMed 2026 Emphasizes RDI, Sustainability, and Global Collaboration
PharmaMed 2026 highlights India’s pharma growth, innovation, and healthcare equity with focus on RDI, APIs self-reliance, and global leadership.
Read MoreRoche Pharma India Strengthens Biopharma Talent Pipeline with NIPER Raebareli Partnership
Roche Pharma India partners NIPER Raebareli to enhance pharma education, research, and industry-academia collaboration in India’s biopharma sector.
Read MoreAMRITVA Cohort 2 Rolls Out Grant Support Under CSR-Backed Pharma Innovation Initiative
AMRITVA Cohort 2 launched as NIPER and Boehringer Ingelheim India sign MoU to strengthen pharma research and grant support for innovators.
Read MoreIndia’s FTAs Open Global Opportunities for MedTech Startups: Piyush Goyal
India urges MedTech Startups to go global using FTAs covering 70% of world GDP, with DPIIT-Pfizer INDovation grants and incubation support.
Read More





